Table 2.
Total n = 118 |
CMV DNAemia | P | ||
---|---|---|---|---|
Yes (n = 21, 17.8%) |
No (n = 97, 82.2%) |
|||
PaO2/FiO2 | 210 (144–286) | 119 (134–270) | 211 (146–287) | 0.439 |
White blood cells (109/L) | 11.6 (8.1–15.8) | 9.9 (6.9–13.0) | 12.1 (8.2–16.2) | 0.098 |
Neutrophils (109/L) | 9.9 (7.0–13.8) | 8.7 (5.4–12.1) | 10.3 (7.0–14.1) | 0.109 |
Lymphocytes (109/L) | 0.5 (0.4–0.8) | 0.6 (0.3–0.8) | 0.5 (0.4–0.8) | 0.855 |
Monocytes (109/L) | 0.5 (0.3–0.9) | 0.3 (0.2–0.8) | 0.5 (0.3–0.9) | 0.130 |
Hemoglobin (g/L) | 92 (74–112) | 71 (69–91) | 98 (79–112) | 0.001# |
Platelet (109/L) | 179 (126–265) | 159 (81–265) | 186 (127–262) | 0.536 |
Procalcitonin (ng/mL) | 1.33 (0.25–8.04) | 1.59 (0.64–17.22) | 1.04 (0.25–6.00) | 0.209 |
Blood lactate (mmol/L) | 1.6 (1.3–2.7) | 1.8 (1.3–2.7) | 1.6 (1.3–2.6) | 0.744 |
PT (s) | 15.2 (14.3–16.4) | 15.9 (14.6–16.6) | 15.2 (14.2–16.3) | 0.373 |
APTT (s) | 43.3 (37.6–51.7) | 44.3 (36.1–56.6) | 43.3 (37.8–51.4) | 0.933 |
Cardiac troponins (ng/ml) | 41.6 (14.7–215.0) | 54.7 (26.4–218.4) | 39.3 (13.7–198.4) | 0.275 |
NT-proBNP (pg/mL) | 1357 (445–5454) | 2518 (1256–11,358) | 1080 (412–4518) | 0.061 |
AST (U/L) | 38.9 (21.9–77.7) | 49.2 (38.7–119.0) | 35.9 (20.6–74.0) | 0.046# |
Albumin (g/L) | 31.5 ± 5.2 | 31.4 ± 5.5 | 31.5 ± 5.1 | 0.921 |
T-BIL (μmol/L) | 13.7 (9.8–20.2) | 13.7 (10.5–20.2) | 13.5 (9.8–18.9) | 0.615 |
Scr (μmol/L) | 90.5 (63.2–169.7) | 120.1 (71.0–213.7) | 89.2 (63.3–147.1) | 0.097 |
BUN (mmol/L) | 10.3 (6.7–17.2) | 13.2 (10.2–19.7) | 10.0 (6.3–15.7) | 0.047# |
ICU Intensive Care Unit, CMV Cytomegalovirus, DNAemia DNA detection by quantitative polymerase chain reaction (qPCR) on peripheral blood samples, PT Prothrombin Time, APTT Activated Partial Thromboplastin Time, NT-proBNP N-terminus Precursor of B-Type Natriuretic Peptide, AST Aspartate Aminotransferase, T-BIL Total Bilirubin, Scr Serum Creatinine, BUN Serum Urea Nitrogen
#P < 0.05; Continuous variables were expressed as Mean ± SD or Median (IQRs); Bold font indicates the difference was statistically significant